Nabel Gary J. — SEC Form 4 filings
SEC reporting owner CIK 1867450. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-24.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-01-10 to 2026-06-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 1 filing — 216,184 shares, $200,427 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: purchase of 108,695 shares @ $0.93 ($100,543) in OPKO HEALTH, INC., filed 2024-01-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| OPKO HEALTH, INC. (OPK) | Chief Innovation Officer, Director | 3 | 3 legs · 216,184 sh · $200,427 | — | 2 |
| SIGA TECHNOLOGIES INC (SIGA) | Director | 3 | — | — | 12 |
| Candel Therapeutics, Inc. (CADL) | Director | 4 | — | — | 4 |
Form 4 filings — Nabel Gary J.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-24 | 4 | Candel Therapeutics, Inc. (CADL) | Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | SIGA TECHNOLOGIES INC (SIGA) | Option exercise (M): 24,116 · Disposition to issuer (D): 7,235 @ $4.39 · Option exercise (M): 24,116 (derivative) @ $0 · Grant/award (A): 34,169 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Candel Therapeutics, Inc. (CADL) | Grant/award (A): 5,353 @ $4.67 | EDGAR |
| 2025-06-18 | 4 | Candel Therapeutics, Inc. (CADL) | Grant/award (A): 14,240 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | SIGA TECHNOLOGIES INC (SIGA) | Option exercise (M): 19,084 · Disposition to issuer (D): 5,725 @ $6.22 · Option exercise (M): 19,084 (derivative) @ $0 · Grant/award (A): 24,116 (derivative) @ $0 | EDGAR |
| 2025-05-29 | 4 | OPKO HEALTH, INC. (OPK) | Grant/award (A): 437,500 (derivative) @ $0 | EDGAR |
| 2024-07-26 | 4 | OPKO HEALTH, INC. (OPK) | Grant/award (A): 437,500 @ $0 | EDGAR |
| 2024-06-27 | 4 | Candel Therapeutics, Inc. (CADL) | Grant/award (A): 14,240 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | SIGA TECHNOLOGIES INC (SIGA) | Option exercise (M): 24,712 · Disposition to issuer (D): 7,414 @ $7.86 · Option exercise (M): 24,712 (derivative) @ $0 · Grant/award (A): 19,084 (derivative) @ $0 | EDGAR |
| 2024-01-10 | 4 | OPKO HEALTH, INC. (OPK) | Purchase (P): 108,695 @ $0.93 · Purchase (P): 500 @ $0.92 · Purchase (P): 106,989 @ $0.93 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1867450 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →